FDA Inspection 988484 — Corden Pharma Colorado, Inc.

Corden Pharma Colorado, Inc. — FEI 1710165

The FDA completed an inspection of Corden Pharma Colorado, Inc. on May 2, 2016 in Boulder, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 2, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boulder, CO (United States)